Key points are not available for this paper at this time.
Although rare globally, endomyocardial fibrosis (EMF) is the leading cause of restrictive cardiomyopathy in some tropical countries. However, its aetiology and pathogenesis remain unclear. Epidemiology data are limited but the highest prevalence has been reported in tropical regions, specifically sub-Saharan Africa. EMF is characterized by apical filling with fibrotic tissue in one or both ventricles, often associated with thrombus and calcification. Most often it extends to the posterior leaflet of the mitral valve, papillary muscle or chordae tendineae, causing atrioventricular valve dysfunction. Transthoracic echocardiography is the first-line modality for assessment, but magnetic resonance imaging has emerged as a more accurate tool for the tissue characterization of this disease.
Martı́nez et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: